Clinical Trial Update: Efficacy and Safety, Long-Term Study of NPC-16 to Treat Dysmenorrhea [Phase 3]

View source ↗

Summary

Phase 3 trial update on NPC-16 for dysmenorrhea reports efficacy and safety findings from long-term study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea

Drugs mentioned

• NPC-16

Snippet

Sponsor: Nobelpharma | Conditions: Dysmenorrhea | Phase 3 | Status: COMPLETED